Ikonisys is a leading cell-based diagnostics company that specializes in cancer diagnosis through rare cancer cell detection. Their flagship product, the Ikoniscope Robotic Microscope, offers highly accurate and reliable detection of rare cells. Powered by the advanced Ikonisoft software system, the Ikoniscope allows for hands-off slide handling and year-round operation.

Ikonisys offers a range of diagnostic applications built on the Ikonisoft engine. These applications, known as oncoFISH, utilize molecular and immunological markers for the detection of cancer-related chromosomal abnormalities. They have FDA clearance and CE certification, making them highly trusted and widely used in the US and Europe.

In addition, Ikonisys has developed the CTC Explorer and CS Explorer applications for the diagnosis of different types of cancer. These applications are extremely valuable in the detection of circulating cancer cells. All diagnostic results from the Ikoniscope/Ikonisoft system are reviewed by expert cytopathologists and cytogeneticists to provide accurate diagnoses.

The company also offers the IkoniWAN application for cloud-based review of slide scans and seamless integration with laboratory information systems. With more than 20 awarded patents and a FDA and GMP compliant facility in New Haven, CT, Ikonisys is committed to providing innovative and high-quality medical diagnostic products that exceed customer expectations and meet the needs of patients. For more information, visit their website or contact them at their headquarters in New Haven, Connecticut